Barinthus Biotherapeutics plc. (BRNS)

Nasdaq · Pharmaceutical Preparations · Inc. X0

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for Barinthus Biotherapeutics plc.. Most notable: 2026-09-09: Filed 8-K disclosing acquisition or disposition of assets. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing acquisition or disposition of assets
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement
  5. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-09-09Wright RobindirectorD48,256——
2026-09-09Scheeren JosephdirectorD23,000——
2026-09-09Phillips Anne M.directorD3,000——
2026-09-09Morgon Pierre A.directorD10,506——
2026-09-09Hooftman LeonofficerA361,530——
2026-09-09Hooftman LeonofficerD361,530——
2026-09-09Hammacher AlexdirectorD3,000——
2026-09-09Enright WilliamdirectorD728,454——
2026-09-09Enright WilliamdirectorD514,923——
2026-09-09DAWES KAREN AdirectorD1,700——
2026-09-09Oxford Science Enterprises plcotherU8,797,7700.11$976,552

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings